FDA Refuses Booster Shot For All Americans But Senior Citizens Only

After a full day of contemplations, questions answers, presentations, and deliberations, the FDA rejected Joe Biden’s Pfizer booster plan for Americans. Instead, a third shot will be administered to elderly Americans only when required. Federal advisers voted 18-0 in favor of recommending Pfizer booster shots for anyone over 65 or anyone who is at high risk of severe disease but declined to recommend it for all Americans.

With the variants challenging the efficacy of the vaccine itself, Biden had chosen the booster shot route for health safety of the masses. If needed, the booster will be administered only six months after having received the second shot.

Pfizer has shared data that the efficacy and protection of the vaccine do tend to wane off with time, as seen in Israel’s case. But the reason FDA approval has been halted over booster shots is the lack of safety data when it comes to younger Americans.

Related Posts

While on one side Biden made a commitment that the booster drive does not start without clearance from regulators, his recent speech advocated for a booster campaign start from September 20. If the FDA signs off on the latest plan for boosters for seniors and health care workers, the CDC also has to weigh in. A key meeting is planned soon by a separate group of experts that advises the CDC and will likely discuss who exactly should get the extra doses.

After that CDC recommendation is made, booster shots would be available through any of the nation’s 40,000 pharmacies, doctors’ offices, and other sites already offering the Pfizer vaccine. Data collected from Israel shows excellent results of booster shots administered amongst senior citizens.

An Israeli study published in a British journal said that there were 11-fold lower rates of infection and nearly 20-fold lower rates of severe Covid-19 among people older than 60 who got a booster dose. A separate Israel Ministry of Health analysis estimated approximately 10-fold improved protection against infection and severe Covid-19 among people who got a booster.

UJM

Recent Posts

AI Adoption Accelerates Across Southeast Asia

AI adoption is accelerating across Southeast Asia as companies and governments invest in automation, data infrastructure, and digital skills to… Read More

January 6, 2026

International Feature Film Oscar Shortlist: 15 Films Advance as Nominations Near

The Academy’s International Feature Film Oscar shortlist is taking shape as 15 countries move forward to the next round of… Read More

January 6, 2026

Oil Prices Show Volatility as Global Demand Signals Remain Mixed

Oil prices volatility has returned as traders react to conflicting indicators on consumption, supply, and policy direction. Global demand signals… Read More

January 6, 2026

Asian Cinema’s Growing Influence on Global Audiences

Asian cinema influence has expanded rapidly as global audiences seek fresh storytelling, distinctive visual styles, and culturally grounded narratives. From… Read More

January 6, 2026

Global Economic Outlook: Recession Fears vs Recovery Signals

The global economic outlook in 2026 sits at a crossroads. On one side, recession fears persist due to sticky inflation… Read More

January 6, 2026

NATO Strengthens Eastern Flank Amid Rising Security Threats

NATO is also working faster to build up its eastern flank against the increasing security threats in border areas in… Read More

January 5, 2026

This website uses cookies.

Read More